You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VY-AADC

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Extension Study for Participants of Prior VY-AADC01

Enrolling by invitation
  • Parkinson's Disease
    • San Francisco, California
      University of California, San Francisco
    Mar 17, 2022

    Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)

    Completed
    • Idiopathic Parkinson's Disease
    • +8 more
    • San Francisco, California
    • +3 more
    Mar 17, 2022

    Parkinson's Disease Trial in United States (VY-AADC02, Sham (Placebo) Surgery)

    Active, not recruiting
    • Parkinson's Disease
    • VY-AADC02
    • Sham (Placebo) Surgery
    • Irvine, California
    • +19 more
    Mar 17, 2022

    Parkinson's Disease Trial in San Francisco, Pittsburgh (VY-AADC01)

    Completed
    • Parkinson's Disease
    • VY-AADC01
    • San Francisco, California
    • +1 more
    Feb 28, 2020

    Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Shanghai (VGN-R09b)

    Recruiting
    • Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
    • Shanghai, No. 1678, Dongfang Road, Pudong New Area, Shanghai, China
      Shanghai Children's Medical Center Affiliated to Shanghai Jiao T
    Mar 9, 2023

    Aromatic L-Amino Acid Decarboxylase Deficiency Trial in Angers, Toulouse (Plasmatic 3-O-Methyldopa dosage)

    Recruiting
    • Aromatic L-Amino Acid Decarboxylase Deficiency
    • Plasmatic 3-O-Methyldopa dosage
    • Angers, France
    • +1 more
    Aug 10, 2022

    AADC Deficiency Trial in Israel, Taiwan, United States (Eladocagene Exuparvovec)

    Recruiting
    • AADC Deficiency
    • Eladocagene Exuparvovec
    • Palo Alto, California
    • +6 more
    Aug 4, 2022

    AADC/TDC in Advanced Parkinson's Disease

    Not yet recruiting
    • Parkinson Disease
      • (no location specified)
      Dec 9, 2022

      Huntington Disease Trial (Intraparenchymal rAAV1 - (mi)RNA HTT)

      Withdrawn
      • Huntington Disease
      • Intraparenchymal rAAV1 - (mi)RNA HTT
      • (no location specified)
      Aug 9, 2021

      AADC Deficiency Trial in San Francisco, Columbus (AAV2-hAADC)

      Recruiting
      • AADC Deficiency
      • San Francisco, California
      • +2 more
      Jan 14, 2022

      Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Taipei (gene therapy)

      Active, not recruiting
      • Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
      • gene therapy
      • Taipei, Taiwan
        National Taiwan University Hospital
      Aug 4, 2021

      COVID-19 Trial (COVID-19 Self testing and related messaging)

      Not yet recruiting
      • COVID-19
      • COVID-19 Self testing and related messaging
      • (no location specified)
      Nov 16, 2022

      Aromatic Amino Acid Decarboxylase Deficiency Trial in Taipei (AAV2-hAADC)

      Active, not recruiting
      • Aromatic Amino Acid Decarboxylase Deficiency
      • Taipei, Taiwan
        National Taiwan University Hospital
      Nov 15, 2021

      Parkinson Disease Trial in Shimotsuke (Cohort1, Cohort2)

      Terminated
      • Parkinson Disease
      • Cohort1
      • Cohort2
      • Shimotsuke, Tochigi, Japan
        Jichi Medical University
      Aug 7, 2019

      Aromatic L-amino Acid Decarboxylase Deficiency

      Completed
      • Aromatic L-amino Acid Decarboxylase Deficiency
        • Taipei, Taiwan
          National Taiwan University Hospital
        Apr 26, 2017

        Neuroblastoma Trial in Taipei

        Unknown status
        • Neuroblastoma
          • Taipei, Taiwan
            National Taiwan University Children Hospital
          Apr 11, 2014